Which tetanus vaccine (tetanus toxoid [TT], tetanus‑diphtheria [Td], or tetanus‑diphtheria‑acellular pertussis [Tdap]) is recommended for administration during pregnancy, and what are their full names?

Tdap (Tetanus-Diphtheria-Acellular Pertussis) is the Recommended Vaccine During Pregnancy

All pregnant women should receive Tdap vaccine during each pregnancy, regardless of prior vaccination history, with optimal timing between 27-36 weeks gestation. 1

Full Forms of Tetanus Vaccines

• TT = Tetanus Toxoid (single antigen)
• Td = Tetanus-Diphtheria toxoids (two antigens)
• Tdap = Tetanus toxoid, reduced Diphtheria toxoid, and acellular Pertussis vaccine (three antigens)

Why Tdap, Not TT or Td?

The critical distinction is that Tdap provides protection against pertussis (whooping cough) in addition to tetanus and diphtheria. 1 This is essential because:

• Infants under 3 months experience the overwhelming majority of pertussis-related morbidity and mortality 2
• Newborns cannot begin their own pertussis vaccine series until approximately 2 months of age 2
• Maternal vaccination transfers protective antibodies to the infant in utero, providing passive immunity during this vulnerable window 1
• Tdap vaccination during pregnancy reduces infant pertussis risk by 36% in the first 6 months of life 3

Specific Vaccination Guidelines

Standard Recommendation

• Administer Tdap between 27-36 weeks gestation during EVERY pregnancy 1
• Vaccinate as early as possible within this window to maximize antibody transfer 2
• This applies even if the woman received Tdap previously, including in a prior pregnancy 1

Special Situations

If tetanus booster is due (>10 years since last Td):

• Give Tdap instead of Td during pregnancy 1
• Optimal timing remains 27-36 weeks 1

For wound management during pregnancy:

• If Td booster is indicated (≥5 years since previous dose), administer Tdap instead 1

For women with unknown or incomplete tetanus vaccination:

• Provide three-dose series: at 0,4 weeks, and 6-12 months 1
• Replace one dose (preferably between 27-36 weeks) with Tdap 1
• Complete remaining doses with Td 1

If Tdap not given during pregnancy:

• Administer immediately postpartum 1

Safety Profile

The evidence strongly supports safety:

• No increased risks of small for gestational age, preterm delivery, stillbirth, or neonatal death 4
• No evidence of major birth defects associated with first, second, or third trimester exposure 5
• Extensive historical data on tetanus toxoid-containing vaccines in pregnancy show no clinically significant severe adverse events 1

Common Pitfall to Avoid

Do not substitute Td for Tdap during pregnancy. While Td protects against tetanus and diphtheria, it lacks the pertussis component that is the primary reason for vaccination during pregnancy. The goal is infant protection against pertussis, not just maternal tetanus/diphtheria immunity. 1

Do not delay vaccination beyond 36 weeks. While Tdap can be given at any time during pregnancy, vaccination after 36 weeks may not allow sufficient time (minimum 2 weeks) for maximal maternal antibody response and transfer before delivery. 1 Preterm infants are at particularly high risk for pertussis and benefit most from early maternal vaccination. 3